RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 127 filers reported holding RHYTHM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,388,143 | +21253.2% | 104,172 | -83.4% | 0.00% | -100.0% |
| Q1 2023 | $11,184 | +807.8% | 626,906 | +1382.1% | 0.01% | +600.0% |
| Q4 2022 | $1,232 | -99.9% | 42,298 | -91.4% | 0.00% | 0.0% |
| Q2 2022 | $2,030,000 | -51.1% | 489,121 | +35.6% | 0.00% | -50.0% |
| Q1 2022 | $4,154,000 | +32.7% | 360,592 | +14.9% | 0.00% | 0.0% |
| Q4 2021 | $3,131,000 | -6.7% | 313,704 | +22.1% | 0.00% | 0.0% |
| Q3 2021 | $3,355,000 | +9.3% | 256,924 | +63.8% | 0.00% | 0.0% |
| Q2 2021 | $3,070,000 | -20.1% | 156,816 | -13.1% | 0.00% | -33.3% |
| Q1 2021 | $3,840,000 | +1746.2% | 180,527 | +2479.0% | 0.00% | – |
| Q4 2020 | $208,000 | -59.3% | 7,000 | -68.6% | 0.00% | -100.0% |
| Q4 2019 | $511,000 | -90.2% | 22,273 | -90.7% | 0.00% | -87.5% |
| Q3 2019 | $5,190,000 | +1087.6% | 240,428 | +1110.9% | 0.01% | +700.0% |
| Q2 2019 | $437,000 | +95.1% | 19,855 | +142.8% | 0.00% | – |
| Q1 2019 | $224,000 | -60.0% | 8,177 | -57.4% | 0.00% | -100.0% |
| Q3 2018 | $560,000 | -37.1% | 19,194 | -32.7% | 0.00% | 0.0% |
| Q2 2018 | $891,000 | – | 28,502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
| NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
| RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
| Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
| Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
| Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
| Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
| Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
| Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |